Gilead Sciences, Inc. (GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	170,941	115,118	100,942	107,677	91,081	73,031
Market Cap Growth	51.34%	14.04%	-6.25%	18.22%	24.72%	-11.16%
Enterprise Value	185,387	131,586	116,722	125,356	111,060	75,312
Last Close Price	137.78	89.86	75.71	77.25	62.49	48.08
PE Ratio	21.45	239.83	17.82	23.45	14.63	593.74
Forward PE	16.29	12.55	10.88	12.90	10.79	8.59
PS Ratio	5.90	4.00	3.72	3.95	3.34	2.96
PB Ratio	7.94	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	18.66	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	17.68	10.63	12.61	11.87	8.00	8.94
PEG Ratio	0.70	0.74	0.93	8.42	-	3.04
EV/Sales Ratio	6.37	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	13.11	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	16.30	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	20.23	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.16	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.74	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.72	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.52	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.39	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.11	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.45	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	40.71%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.57%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Invested Capital (ROIC)	24.42%	19.78%	18.93%	21.25%	21.68%	1.80%
Return on Capital Employed (ROCE)	24.60%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	4.74%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	5.36%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	2.29%	3.43%	3.96%	3.78%	4.54%	5.66%
Payout Ratio	49.20%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-1.02%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	1.27%	3.67%	4.28%	3.86%	4.62%	6.75%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q